Home
Scholarly Works
COX-2 specific inhibition with MK-0663 120 mg q.d....
Conference

COX-2 specific inhibition with MK-0663 120 mg q.d. over 4 weeks did not increase fecal blood loss: A controlled study with placebo and ibuprofen 800 mg t.i.d.

Authors

Hunt RH; Bowen B; James C; Marshall J; Simon T; Callegari P; Cagliola A; Yu C; Lines C

Volume

120

Pagination

pp. A597-A597

Publisher

W B SAUNDERS CO

Publication Date

April 1, 2001

Conference proceedings

GASTROENTEROLOGY

Issue

5

ISSN

0016-5085

Contact the Experts team